ANNOUNCING THE HIGH PRIORITY, SHORT-TERM PROJECT AWARD (R56) 

RELEASE DATE:  June 15, 2004

NOTICE:  NOT-OD-04-047 

(NHLBI Notice of Intent to Participate in this (R56) see NOT-HL-13-188)

March 23, 2017: Notice of NHGRI's Participation in NOT-OD-04-047  NOT-HG-17-004 
November 27, 2009 - See Notice NOT-NS-10-004 NINDS Notice of Intent to Participate in the High Priority, Short-Term Project Award (R56). (NIDCD Notice of Intent to Participate in this (R56) see NOT-DC-09-001) (NIDCR Intent to participate in this R56, see NOT-DE-07-002) (NIMH now accepting R56, see NOT-MH-05-003) National Human Genome Research Institute (NHGRI)
National Institute of Allergy and Infectious Diseases (NIAID) (http://www.niaid.nih.gov) National Cancer Institute (NCI) (http://www.nci.nih.gov) National Institute on Alcohol Abuse and Alcoholism (NIAAA) (http://www.niaaa.nih.gov) National Center on Complementary and Alternative Medicine (NCCAM) (http://www.nccam.nih.gov) National Institute on Aging (NIA) (http://www.nia.nih.gov) National Institute of Environmental Health Sciences (NIEHS) (http://www.niehs.nih.gov) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (http://www.niddk.nih.gov) National Institute on Drug Abuse (NIDA) (http://www.nida.nih.gov) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (http://www.niams.nih.gov) National Library of Medicine (NLM) (http://www.nlm.nih.gov/) National Institute of Mental Health (NIMH) (added per NOT-MH-05-003) (http://www.nimh.nih.gov) National Institute of Dental and Craniofacial Research (NIDCR) (added per NOT-DE-07-002) (http://www.nidcr.nih.gov/) National Institute on Deafness and Other Communication Disorders (NIDCD) (added per NOT-DE-07-002) (http://www.nidcd.nih.gov/) National Institute of Neurological Disorders and Stroke (NINDS) (added per NOT-NS-10-004) (http://www.ninds.nih.gov)
National Institute of Biomedical Imaging and Bioengineering (NIBIB) (added as per NOT-EB-17-011) NIH announces the new NIH High Priority, Short-Term Project Award (R56). R56 grants will be awarded beginning in Fiscal Year 2005. The new R56 grant will fund, for one or two years, high-priority new or competing renewal R01 applications that fall just outside the limits of funding of the participating NIH Institutes and Centers. INVESTIGATORS MAY NOT APPLY FOR AN R56 GRANT. Recipients of R56 awards will be selected by IC staff from R01 applications that fall at or near the payline margins Additional information is available at http://grants.nih.gov/grants/funding/r56.htm DESCRIPTION The R56 Award will provide limited, interim research support based on the merit of a pending application. The R56 will enable an applicant to gather additional data for revision of a new or competing renewal application. R56 funding will end after one or two years or when the applicant succeeds in obtaining traditional project funding. The High Priority, Short-Term Project Awards will underwrite highly meritorious applications with funds that can range up to initial review group recommended levels. The R56 award will help early career stage scientists trying to establish research careers as well as more experienced scientists who just miss getting funded. The R56 will provide interim funding while they revise their applications. FEATURES A. The R56 grant will be available to domestic R01 applicants only. B. Investigators may not apply for an R56 grant. C. Competing R01 applications prepared and submitted in accordance with NIH procedures will be peer reviewed and assigned a priority score and in most cases a percentile rating. Nominees for the R56 will come from the R01 applications pending for the current fiscal year. Nominees for the award must be in the most meritorious half of the priority or percentile range. Previously approved, but inactivated, applications from this time period may be considered and if awarded will be converted to an R56. D. The awards may be funded up to the IRG recommended and Council approved levels and indirect costs will be provided at the negotiated rate. E. R56 awardees will be encouraged to submit a revision of their original competing application at the earliest convenient date to be considered for future funding. Applicants are reminded that the limitations and the number of amendments described at http://grants.nih.gov/grants/guide/notice-files/NOT-OD-03-041.html apply to all subsequent revisions. F. If a revised competing application is funded while an R56 award is active, the balance of the R56 Award will be deducted from the approved amount of the competing award. G. A final progress report, final financial status report, and final invention statement (HHS 568) will be required 90 days after the end of the R56 grant period. The progress report must identify those portions of the original proposal pursued with the R56 Award. If the awardee is successful with a subsequent application, the progress report in the revised application will suffice as a progress report for the R56 Award and a final invention statement will not be required. REVIEW CRITERIA AND PROCEDURES NIH staff, initial review groups, and the institute and Center Advisory Councils and Boards will review R01 applications in the usual manner. Program administrators will identify and nominate applications near the payline for conversion to an R56. Awards will be selected based on the scientifically creative and innovative approaches that meet the mission of the Institute or Center. INQUIRIES For information concerning the new R56 Award, contact: PARTICIPATING NIH INSTITUTES National Institute of Allergy and Infectious Diseases (NIAID) Allan Czarra Deputy Director, DEA, NIAID, NIH, DHHS Room 2140 6700-B Rockledge Drive - MSC 7610 Bethesda, MD 20892-7610 For express deliveries, use ZIP code 20817-7610 Phone: (301) 496-7291 FAX: (301) 402-0369 E-mail: aczarra@niaid.nih.gov Website: http://www.niaid.nih.gov National Cancer Institute (NCI) Christopher L. Hatch, Ph.D. Chief, Program Coordination and Referral Branch Division of Extramural Activities National Cancer Institute 6116 Executive Blvd., Room 8047 Bethesda, MD 20892-8329 Rockville, MD 20852 (for express/courier delivery) Phone: 301-594-1403 Fax: 301-402-0275 Email: hatchc@mail.nih.gov Website: http://www.nci.nih.gov National Institute on Alcohol Abuse and Alcoholism (NIAAA) Kenneth R. Warren, Ph.D. Director, Office of Scientific Affairs 5635 Fishers Lane Bethesda, MD 20892-1705 Phone: 301-443-5494 Fax: 301-443-7043 Email: kwarren@mail.nih.gov Website: http://www.niaaa.nih.gov National Center on Complementary and Alternative Medicine (NCCAM) Richard L. Nahin, Ph.D., MPH Senior Advisor for Scientific Coordination and Outreach National Center for Complementary and Alternative Medicine 9000 Rockville Pike Bldg. 31, Rm. 2B11 MSC 2182 Bethesda, MD 20892-2182 phone: 301-496-7801 fax: 301-435-6549 email: nahinr@mail.nih.gov Website: http://www.nccam.nih.gov National Institute on Aging (NIA) Dr. Miriam F. Kelty, Ph.D Associate Director, Extramural Activities 7201 Wisconsin Ave, Room 2C218, MSC 2292 Bethesda, MD 20892 Phone: 301-496-9322 Fax: 301-402-2945 Email: mk46u@nih.gov Website: http://www.nia.nih.gov National Institute of Environmental Health Sciences (NIEHS) Anne P. Sassaman Director, Division of Extramural Research and Training National Institute of Environmental Health Sciences National Institutes of Health P.O. Box 12233 Research Triangle Park, NC. 27709 Phone: (919) 541-7723 Fax: (919) 541-2843 Email: sassaman@niehs.nih.gov Website: http://www.niehs.nih.gov National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Joyce A. Hunter, Ph.D. Deputy Director Division of Extramural Activities National Institute of Diabetes and Digestive and Kidney Diseases Two Democracy Plaza, Room 714 6707 Democracy Boulevard Bethesda, MD 20892-5456 Phone: (301) 594-0056 Fax: (301) 480-4125 Email: jh602o@nih.gov Website: http://www.niddk.nih.gov National Institute on Drug Abuse (NIDA) Teresa Levitin, Ph.D. Director, Office of Extramural Affairs 6101 Executive Blvd, Room 220 MSC 8401 Bethesda, MD 20892-8401 Phone: 301 443-2755 Fax: 303 443-0538 Email: TL25u@nih.gov Website: http://www.nida.nih.gov National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Cheryl A. Kitt, Ph.D. Director, Extramural Program National Institute of Arthritis and Musculoskeletal and Skin Diseases NIH, DHHS One Democracy Plaza 6701 Democracy Blvd., Room 804 Bethesda, MD 20892-4872 Tel: 301-594-2463 Fax: 301-480-4543 Email: kittc@mail.nih.gov Website: http://www.niams.nih.gov National Library of Medicine (NLM) Valerie Florance, Ph.D. Deputy Director, Division of Extramural Programs Rockledge 1, Suite 301, 6705 Rockledge Drive Bethesda, MD 20892 Phone: (301) 594-4882 Fax (301) 402-2952 Email: floranv@mail.nih.gov Website: http://www.nlm.nih.gov/ep


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices



NIH Office of Extramural Research Logo
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy
NIH... Turning Discovery Into Health®



Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.